Quick Answer
Lunai Bioworks Inc. reported Total Revenue of $42.8 thousand for fiscal year 2016.
Lunai Bioworks Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — | — |
| Net Income | -$178.01M -101.3% |
-$88.43M -122.8% |
-$39.68M +65.0% |
-$113.43M -324.5% |
-$26.72M -134.1% |
-$11.42M +36.6% |
| Diluted EPS | -$1.08 -18.7% |
-$0.91 -28.2% |
-$0.71 +67.1% |
-$2.16 | — | — |
| Total Assets | $8.23M -95.0% |
$163.13M +179.8% |
$58.30M -31.1% |
$84.63M -55.4% |
$189.61M +6.5% |
$178.10M -1.0% |
| Cash and Equivalents | $92.7K -58.0% |
$220.5K -88.2% |
$1.87M -79.6% |
$9.17M -55.6% |
$20.66M +137.6% |
$8.70M -29.2% |
| Stockholders Equity | -$21.35M -116.2% |
$131.98M +183.8% |
$46.50M -36.0% |
$72.62M -58.4% |
$174.66M +5.0% |
$166.27M -3.9% |
| R&D Expense | $537.4K -80.2% |
$2.71M -35.0% |
$4.17M -50.3% |
$8.37M -46.7% |
$15.72M +234.9% |
$4.69M +87.9% |
| Operating Income | -$188.97M -131.5% |
-$81.64M -111.7% |
-$38.56M +66.8% |
-$116.08M -396.0% |
-$23.40M -96.3% |
-$11.92M -8.5% |
| Gross Profit | — | — | — | — | — | — |
| Shares Outstanding | 177.39M +12.0% |
158.45M +148.8% |
63.70M +20.2% |
53.01M +1.5% |
52.22M +12.3% |
46.50M +2.7% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | December 31, 2015 | $42.5K | — | +4497.3% |
| Net Income | December 31, 2025 | -$1.80M | +75.2% | -163.8% |
| Diluted EPS | December 31, 2025 | -$0.08 | +82.2% | -161.5% |
| Total Assets | December 31, 2025 | $6.67M | -94.0% | -4.2% |
| Cash and Equivalents | December 31, 2025 | $491.6K | +57.7% | -21.3% |
| Stockholders Equity | December 31, 2025 | -$13.55M | -116.5% | -3.9% |
| R&D Expense | December 31, 2025 | $45.9K | -71.5% | +87.9% |
| Operating Income | December 31, 2025 | -$1.82M | +59.9% | +44.9% |
| Gross Profit | December 31, 2015 | $37.3K | +153.1% | +183.5% |
| Shares Outstanding | December 31, 2025 | 24.19M | -85.1% | +4.3% |
- Lunai Bioworks Inc. reported Total Revenue of $42.8 thousand for fiscal year 2016.
- Lunai Bioworks Inc. reported Net Income of -$178.01 million for fiscal year 2025.
- Lunai Bioworks Inc. showed a decrease of -101.3% in Net Income compared to the prior fiscal year.
- Lunai Bioworks Inc. reported Diluted EPS of $1.08 per share (loss) for fiscal year 2025.
- Lunai Bioworks Inc. showed a decrease of -18.7% in Diluted EPS compared to the prior fiscal year.
- Lunai Bioworks Inc. reported Total Assets of $8.23 million for fiscal year 2025.
- Lunai Bioworks Inc. showed a decrease of -95.0% in Total Assets compared to the prior fiscal year.
- Lunai Bioworks Inc. reported Cash and Equivalents of $92.7 thousand for fiscal year 2025.
- Lunai Bioworks Inc. showed a decrease of -58.0% in Cash and Equivalents compared to the prior fiscal year.
- Lunai Bioworks Inc. reported Stockholders Equity of -$21.35 million for fiscal year 2025.
- Lunai Bioworks Inc. showed a decrease of -116.2% in Stockholders Equity compared to the prior fiscal year.
- Lunai Bioworks Inc. reported R&D Expense of $537.4 thousand for fiscal year 2025.
- Lunai Bioworks Inc. showed a decrease of -80.2% in R&D Expense compared to the prior fiscal year.
- Lunai Bioworks Inc. reported Operating Income of -$188.97 million for fiscal year 2025.
- Lunai Bioworks Inc. showed a decrease of -131.5% in Operating Income compared to the prior fiscal year.
- Lunai Bioworks Inc. reported Gross Profit of $37.5 thousand for fiscal year 2016.
- Lunai Bioworks Inc. showed an increase of +112.7% in Gross Profit compared to the prior fiscal year.
- Lunai Bioworks Inc. reported Shares Outstanding of 177.39 million shares for fiscal year 2025.
- Lunai Bioworks Inc. showed an increase of +12.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: